Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. - Salazar-Camelo A; Vega L; Fadlallah Y; Bou Rjeily N; Balshi A; Morris B; Ghajarzadeh M; Mowry EM; Waubant E; Nourbakhsh B (Multiple sclerosis (Houndmills, Basingstoke, England), 2025)